BioPortfolio - NUVASIVE
NuVasive Uk Ltd - BioPortfolio. ... Recent Search Terms used to find this page: nuvasive locations | nuvasive email contact | NuVasive Uk Ltd .. ...
http://www.bioportfolio.com/search/NUVASIVE.html...
|
NuVasive, Inc. Acquires Biologic Product Platform - News, Search ...
Contact: Investors: Kevin C. O'Boyle Nick Laudico EVP & Chief Financial Officer The Ruth Group NuVasive, Inc. 646-536-7030 858-909-1800 ...
http://www.biospace.com/news_story.aspx?NewsEntityId=43688...
|
BioPortfolio - NuVasive
NuVasive - Entry on Bioportfolio's Biocorporate Database. ... Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or
BioEmail ...
http://www.bioportfolio.com/biocorporate/32533-NuVasive.html...
|
NuVasive to Present at Thomas Weisel Partners Healthcare ...
Contact: Kevin C. O'Boyle EVP & Chief Financial Officer NuVasive, Inc. 858-909- 1800 investorrelations@nuvasive.com Investors: Nick Laudico/Zack Kubow The ...
http://biz.yahoo.com/prnews/080829/nyf007.html...
|
BioPortfolio - NuVasive - Profile
View the current NuVasive Page on BioPortfolio.com. (http://www.bioportfolio.com /biocorporate/32533-NuVasive.html). Contact Details: ...
http://www.bioportfolio.com/biocorporate/32533-NuVasive.pdf...
|
NuVasive, Inc. to Relocate to New Campus Headquarters - News ...
CONTACT: Kevin C. O'Boyle, EVP & Chief Financial Officer of NuVasive, Inc., +1- 858-909-1800, investorrelations@nuvasive.com; or Investors, Nick ...
http://www.biospace.com/news_story.aspx?NewsEntityId=76839...
|
NuVasive to Offer $200 Million Convertible Senior Notes Due 2013
The notes will be convertible into shares of NuVasive common stock. ... Contact: Kevin C. O'Boyle EVP & Chief Financial Officer NuVasive, Inc. 858-909-1800 ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=...
|
NUVASIVE Special 510(k) Premarket Notification Plus System FEB 1 7 ...
The NuVasive SmartPlate Gradient Plus System consists. of a variety of plates, screws, and .... contact the Office of Compliance. at (240) 276-0210. Also, ...
http://www.fda.gov/cdrh/pdf5/K053581.pdf...
|
Osiris and NuVasive Enter into Definitive Agreement for Osteocel
8 May 2008 ... However, included in the agreement is an option for NuVasive to acquire the .... For additional information, please contact: ...
http://www.osiristx.com/pdf/PR%2078%2008May08%20Osiris%20Ent...
|
Special 5 1 O(k) Premarket Notification Neuro Vision@ JJB System ...
NuVasive@, Inc. VII. 510(k) Summary. In accordance with Title 2 1 of the Code of Federal .... contact the Office of Compliance at (301) 594-4659. ...
http://www.fda.gov/cdrh/pdf3/k032083.pdf...
|
